Preoperative VolumE Replacement therapy in DIabetic patients undergoing coronary artery bypass grafting surgery: results from an open parallel group randomized Controlled Trial (VeRDiCT)
- 20 September 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 30 (1) , 54-63
Abstract
OBJECTIVES: To investigate the effect of preoperative volume replacement therapy (VRT) on renal function, health outcome and time to fitness for discharge in diabetic patients undergoing coronary artery bypass grafting (CABG). METHODS: In 2 parallel randomized controlled trials, diabetic patients were allocated to preoperative VRT (1 ml/kg/h of Hartmann’s solution for 12 h) or usual care. Primary outcome was time to fitness for discharge. Secondary outcomes included acute kidney injury, postoperative complications, patient-reported quality of life (QoL), hospital resource use and markers of renal, cardiac and inflammatory injury. RESULTS: In total, 169 patients were randomized (84 VRT, 85 usual care; mean age 64 years; 88% male). Time to fitness for discharge was similar between groups [median 6 days; interquartile range 5.0–9.0 in both groups; hazard ratio 0.95, 95% confidence interval (CI) 0.65–1.38; P = 0.78]. Postoperative acute kidney injury was not statistically different (VRT: 27.7% vs usual care: 18.8%, odds ratio 1.72, 95% CI 0.82–3.59; P = 0.15). Estimated glomerular filtration rate (mean difference −0.92, 95% CI −4.18 to 2.25; P = 0.56), microalbumin/creatinine ratio [geometric mean ratio (GMR) 1.16, 95% CI 0.94–1.42; P = 0.16], N-acetyl-beta-d-glucosaminidase (GMR 1.08, 95% CI 0.83–1.40; P = 0.57), C-reactive protein (GMR 1.00, 95% CI 0.88–1.13; P = 0.94), troponin T (Trop-T; GMR 1.18, 95% CI 0.78–1.79; P = 0.39) and other secondary health outcomes were similar between groups. QoL improved in both groups at 3 months with no difference observed. CONCLUSIONS: The use of preoperative VRT is not superior to usual care in diabetic patients undergoing CABG. Clinical trial registration number: ISRCTN02159606.Keywords
Funding Information
- Garfield Weston Trust (PMS/MMS—07/08–3001)
- NIHR Bristol Cardiovascular Biomedical Research Centre
This publication has 25 references indexed in Scilit:
- Acute kidney injury following coronary artery bypass grafting: early mortality and postoperative complicationsScandinavian Cardiovascular Journal, 2012
- Cardiac Surgery–Associated Acute Renal Injury: New Paradigms and Innovative TherapiesJournal of Cardiothoracic and Vascular Anesthesia, 2010
- Inadequate Blood Glucose Control Is Associated With In-Hospital Mortality and Morbidity in Diabetic and Nondiabetic Patients Undergoing Cardiac SurgeryCirculation, 2008
- The effect of diabetes mellitus on patients undergoing coronary surgery: A risk-adjusted analysisThe Journal of Thoracic and Cardiovascular Surgery, 2006
- American Society of Nephrology Renal Research ReportJournal of the American Society of Nephrology, 2005
- Effect of Risk-Adjusted Diabetes on Mortality and Morbidity After Coronary Artery Bypass SurgeryThe Annals of Thoracic Surgery, 2005
- Influence of renal dysfunction on mortality after cardiac surgery: Modifying effect of preoperative renal functionKidney International, 2005
- Coronary revascularisation outcome questionnaire (CROQ): development and validation of a new, patient based measure of outcome in coronary bypass surgery and angioplastyHeart, 2004
- Independent Association between Acute Renal Failure and Mortality following Cardiac SurgeryThe American Journal of Medicine, 1998
- A SCORING METHOD (ASEPSIS) FOR POSTOPERATIVE WOUND INFECTIONS FOR USE IN CLINICAL TRIALS OF ANTIBIOTIC PROPHYLAXISThe Lancet, 1986